###begin article-title 0
###xml 25 28 25 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 130 135 <span type="species:ncbi:9606">Human</span>
Regulating Factors of PrPres Glycosylation in Creutzfeldt-Jakob Disease - Implications for the Dissemination and the Diagnosis of Human Prion Strains
###end article-title 0
###begin p 1
Conceived and designed the experiments: EL ILP SH. Performed the experiments: EL ILP M KP. Analyzed the data: EL ILP BF JJH SH. Contributed reagents/materials/analysis tools: NP KP VS JPB JJH SH. Wrote the paper: EL ILP BF KP JPB JJH SH.
###end p 1
###begin title 2
Objective
###end title 2
###begin p 3
###xml 51 54 51 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 222 225 222 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 344 347 344 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 391 399 <span type="species:ncbi:9606">patients</span>
The glycoprofile of pathological prion protein (PrPres) is widely used as a diagnosis marker in Creutzfeldt-Jakob disease (CJD) and is thought to vary in a strain-specific manner. However, that the same glycoprofile of PrPres always accumulates in the whole brain of one individual has been questioned. We aimed to determine whether and how PrPres glycosylation is regulated in the brain of patients with sporadic and variant Creutzfeldt-Jakob disease.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 3 6 3 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 150 154 150 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRNP</italic>
###xml 187 190 187 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 52 60 <span type="species:ncbi:9606">patients</span>
PrPres glycoprofiles in four brain regions from 134 patients with sporadic or variant CJD were analyzed as a function of the genotype at codon 129 of PRNP and the Western blot type of PrPres.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 32 35 32 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 126 129 126 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 261 264 261 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 349 352 349 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
The regional distribution of PrPres glycoforms within one individual was heterogeneous in sporadic but not in variant CJD. PrPres glycoforms ratio significantly correlated with the genotype at codon 129 of the prion protein gene and the Western blot type of PrPres in a region-specific manner. In some cases of sCJD, the glycoprofile of thalamic PrPres was undistinguishable from that observed in variant CJD.
###end p 7
###begin title 8
Interpretation
###end title 8
###begin p 9
###xml 40 43 40 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 144 147 144 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 82 90 <span type="species:ncbi:9606">patients</span>
Regulations leading to variations of PrPres pattern between brain regions in sCJD patients, involving host genotype and Western blot type of PrPres may contribute to the specific brain targeting of prion strains and have direct implications for the diagnosis of the different forms of CJD.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 358 361 358 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 410 411 410 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
###xml 535 536 535 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
###xml 545 548 545 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 548 551 548 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Bolton1">[1]</xref>
###xml 553 556 553 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Prusiner1">[2]</xref>
###xml 723 726 723 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Pocchiari1">[3]</xref>
###xml 950 953 950 953 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 1018 1022 1018 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRNP</italic>
###xml 1056 1059 1056 1059 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 1233 1236 1233 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Monari1">[4]</xref>
###xml 1300 1303 1300 1303 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 1303 1306 1303 1306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Parchi1">[5]</xref>
###xml 1414 1418 1414 1418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRNP</italic>
###xml 1418 1421 1418 1421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Parchi2">[6]</xref>
###xml 1465 1468 1465 1468 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 1631 1634 1631 1634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Parchi3">[7]</xref>
###xml 1750 1753 1750 1753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Head1">[8]</xref>
###xml 1812 1815 1812 1815 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 1871 1874 1871 1874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Puoti1">[9]</xref>
###xml 1953 1957 1953 1957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Endo1">[10]</xref>
###xml 2162 2165 2162 2165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 2214 2217 2214 2217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Head1">[8]</xref>
###xml 2502 2506 2502 2506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Collinge1">[11]</xref>
###xml 2735 2737 2735 2737 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nd</sup>
###xml 2757 2761 2757 2761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-DeArmond1">[12]</xref>
###xml 2977 2981 2977 2981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Tuzi1">[13]</xref>
###xml 2992 2995 2992 2995 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 561 567 <span type="species:ncbi:9606">humans</span>
###xml 739 747 <span type="species:ncbi:9606">patients</span>
###xml 1844 1852 <span type="species:ncbi:9606">patients</span>
###xml 1876 1881 <span type="species:ncbi:9606">Human</span>
###xml 2205 2213 <span type="species:ncbi:9606">patients</span>
###xml 2414 2420 <span type="species:ncbi:9606">humans</span>
###xml 2676 2691 <span type="species:ncbi:10090">transgenic mice</span>
###xml 2815 2819 <span type="species:ncbi:10090">mice</span>
###xml 3078 3083 <span type="species:ncbi:9606">human</span>
Human prion diseases are fatal neurodegenerative diseases. They are clinically characterized by progressive dementia associated with various neurological symptoms and neuropathologically by spongiosis, gliosis and neuronal loss in the brain. An almost constant biochemical hallmark is the accumulation of an abnormal partially protease-resistant isoform (PrPres) of the host-encoded cellular prion protein (PrPc). According to the protein only hypothesis, the mechanism for prion propagation is thought to involve the conversion of PrPc into PrPres[1], [2]. In humans, prion disorders occur in acquired, inherited and sporadic forms. Sporadic Creutzfeldt-Jakob disease (sCJD) accounts for more than 80 percent of the cases [3]. Among sCJD patients, a wide range of clinical and neuropathological phenotypes is observed. Recently, efforts have focused on the molecular basis of such phenotypical diversity considering the biochemical properties of PrPres and the presence of polymorphisms within the gene encoding PrP (PRNP). Indeed, a classification of PrPres Western blot patterns, obtained after proteinase K (PK) digestion which leads to PK-resistant core fragments of either 21 kDa (type 1) or 19 kDa (type 2), has been proposed [4]. This difference results from distinct PK cleavage sites of PrPres[5]. Another contribution to the sCJD heterogeneity is the methionine/ valine polymorphism at the codon 129 of PRNP[6]. By correlating codon 129 genotypes and PrPres types to clinical and pathological features in a series of 300 sporadic CJD, six molecular combinations corresponding to some phenotypic variants were identified [7]. However, these observations are based on the postulate that the same PrP conformer accumulates in the whole brain [8]. This has been recently questioned since more than one PrPres type in the brain from sCJD patients has been observed [9]. Human prion protein has two sites of N-glycosylation at residues 181 and 197 [10]. Depending on the occupation of these sites, different glycoforms are identified on Western blot, the proportion of which may vary between prion strains. For example, a higher amount of diglycosylated PrPres (type 2B) distinguishes vCJD from sCJD patients [8]. This particular pattern is retained when the type 2B prion strain is transmitted from one species to another. This contributed to the identification of the BSE as the origin of vCJD epidemics in humans, suggesting that protein glycosylation may be part of specific strain properties [11]. Glycosylation seems also to be involved in the targeting of brain regions by prions leading to strain-specific lesion profiles as previously suggested in a study using transgenic mice overexpressing hamster PrP mutated at the 2nd glycosylation site [12]. Other results recently obtained using gene-targeted mice showed also that N-linked glycosylation of the prion protein influences lesion profile and plaque occurrence induced by some experimental strains of scrapie [13]. While PrPres glycosylation is a key factor in strain diagnosis and probably brain targeting in human diseases, whether it is regulated between brain regions, and how, remains largely unknown.
###end p 11
###begin p 12
###xml 37 40 37 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 167 171 167 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRNP</italic>
###xml 201 204 201 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 244 247 244 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 114 122 <span type="species:ncbi:9606">patients</span>
Hence, we analyzed the pattern of PrPres glycosylation from four different brain regions in a large series of 134 patients with CJD and investigated how brain region, PRNP genotype at codon 129 and PrPres type may affect the accumulation of PrPres glycotypes.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
Classification of CJD cases
###end title 14
###begin p 15
###xml 45 48 45 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRNP</italic>
###xml 192 197 192 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002786-g001">Fig 1</xref>
###xml 202 209 202 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002786-t001">Table 1</xref>
###xml 288 291 288 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Head1">[8]</xref>
###xml 367 370 367 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 182 190 <span type="species:ncbi:9606">patients</span>
###xml 301 309 <span type="species:ncbi:9606">patients</span>
Using results from Western blot typing of PrPres and PRNP genotyping, we obtained a distribution of the different molecular subtypes of sCJD cases with a predominance of MM1 and VV2 patients (Fig 1 and Table 1), consistent with the distribution reported by Head et al. in a UK population [8]. All the patients with vCJD were methionine homozygotes and had type 2B PrPres.
###end p 15
###begin title 16
###xml 19 22 19 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 55 62 <span type="species:ncbi:9606">patient</span>
Western blot of PrPres in different brain regions of a patient with sporadic Creutzfeldt-Jakob disease using the 3F4 reference antibody.
###end title 16
###begin p 17
###xml 11 14 11 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
Type of PrPres in frontal cortex (F), occipital cortex (O), thalamus (T) and cerebellum (C) was determined using type 1, type 2A and type 2B standards after PK digestion.
###end p 17
###begin title 18
Description of sporadic and variant Creutzfeldt-Jakob disease populations.
###end title 18
###begin p 19
###xml 123 127 123 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRNP</italic>
###xml 222 225 222 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
Number of sporadic CJD (sCJD) cases and variant CJD (vCJD) cases are distributed according to the genotype at codon 129 of PRNP (MM: methionine homozygote, VV: valine homozygote, MV: methionine-valine heterozygote) and PrPres type (type 1, type 2A or type 2B). Absolute numbers of cases are indicated and the percentage of total is shown in round brackets.
###end p 19
###begin title 20
###xml 26 29 26 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 54 62 <span type="species:ncbi:9606">patients</span>
Regional variations of PrPres glycoform ratio in sCJD patients
###end title 20
###begin title 21
Frontal cortex versus occipital cortex
###end title 21
###begin p 22
###xml 71 77 71 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002786-g002">Fig 2A</xref>
###xml 316 322 316 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002786-g002">Fig 2A</xref>
No difference was observed between these two regions as illustrated on Fig 2A, left panel. The three glycoforms were evenly distributed in both regions. The proportion of di- and nonglycosylated forms in the frontal cortex correlated well with those observed in the occipital cortex (regression analysis: r = 0,58) (Fig 2A, right panel).
###end p 22
###begin title 23
###xml 26 29 26 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 61 69 <span type="species:ncbi:9606">patients</span>
Regional variations of PrPres glycoforms in brains from sCJD patients.
###end title 23
###begin p 24
###xml 3 6 3 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 154 161 <span type="species:ncbi:9606">patient</span>
PrPres glycoform ratios from the frontal and occipital cortex were not statistically different (A, left panel). Each dot represents one brain area from a patient and is defined on the ternary plot by three coordinates corresponding to the relative intensity of di-, mono- and nonglycosylated bands. The correlation between diglycosylated forms from these two regions is shown on the regression curve (A, right panel). The thalamus exhibited more diglycosylated forms and less nonglycosylated forms than the occipital cortex (B). The cerebellum exhibited more monoglycosylated forms than the cortical regions (C). More diglycosylated forms were also detected in the thalamus when compared with the cerebellum, which showed more monoglycosylated forms (D).
###end p 24
###begin title 25
Frontal or occipital cortex versus thalamus
###end title 25
###begin p 26
###xml 3 6 3 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 249 255 249 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002786-g002">Fig 2B</xref>
PrPres glycoform ratios from the frontal cortex and the thalamus were not statistically different. However, they differed significantly between the occipital cortex and the thalamus, which showed more diglycosylated forms than the occipital cortex (Fig 2B).
###end p 26
###begin title 27
Frontal or occipital cortex versus cerebellum
###end title 27
###begin p 28
###xml 130 136 130 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002786-g002">Fig 2C</xref>
Compared to the frontal and the occipital isocortices, a higher proportion of monoglycosylated forms was found in the cerebellum (Fig 2C). Frontal cortex exhibited more diglycosylated and nonglycosylated forms than the cerebellum.
###end p 28
###begin title 29
Cerebellum versus thalamus
###end title 29
###begin p 30
###xml 155 161 155 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002786-g002">Fig 2D</xref>
Higher amounts of diglycosylated forms were detected in the thalamus while an increased accumulation of monoglycosylated forms occurred in the cerebellum (Fig 2D).
###end p 30
###begin title 31
###xml 26 29 26 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 54 62 <span type="species:ncbi:9606">patients</span>
Regional variations of PrPres glycoform ratio in vCJD patients
###end title 31
###begin p 32
###xml 96 99 96 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 22 30 <span type="species:ncbi:9606">patients</span>
In the 11 French vCJD patients that we studied, we consistently observed the typical type 2B PrPres profile whithout any significant difference between brain regions.
###end p 32
###begin title 33
###xml 49 52 49 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
Influence of the PrP genotype at codon 129 on PrPres glycoform ratio
###end title 33
###begin title 34
MM genotype
###end title 34
###begin p 35
###xml 85 95 85 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002786-g003">Fig 3A, 3B</xref>
###xml 116 128 116 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002786.s001">Fig S1A, S1B</xref>
###xml 141 153 141 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002786.s002">Fig S2A, S2B</xref>
###xml 171 183 171 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002786.s003">Fig S3A, S3B</xref>
A significant increase of monoglycosylated forms was observed in the frontal cortex (Fig 3A, 3B), occipital cortex (Fig S1A, S1B), thalamus (Fig S2A, S2B) and cerebellum (Fig S3A, S3B), compared to MV and VV genotypes.
###end p 35
###begin title 36
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRNP</italic>
###xml 43 46 43 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 96 104 <span type="species:ncbi:9606">patients</span>
Influence of PRNP codon 129 genotype on PrPres glycoform ratios in the frontal cortex from sCJD patients.
###end title 36
###begin p 37
###xml 42 49 <span type="species:ncbi:9606">patient</span>
###xml 254 262 <span type="species:ncbi:9606">patients</span>
###xml 331 339 <span type="species:ncbi:9606">patients</span>
###xml 400 408 <span type="species:ncbi:9606">patients</span>
Each dot represents one brain area from a patient and is defined on the ternary plot by three coordinates corresponding to the relative intensity of di-, mono- and nonglycosylated bands. More monoglycosylated forms were detected in methionine homozygote patients compared to other genotypes (A, B). Methionine/ valine heterozygote patients showed more nonglycosylated forms (A, C). Valine homozygote patients had more diglycosylated forms (B, C).
###end p 37
###begin title 38
MV genotype
###end title 38
###begin p 39
###xml 16 26 16 26 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002786-g003">Fig 3A, 3C</xref>
###xml 47 59 47 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002786.s001">Fig S1A, S1C</xref>
###xml 72 84 72 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002786.s002">Fig S2A, S2C</xref>
###xml 102 114 102 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002786.s003">Fig S3A, S3C</xref>
Frontal cortex (Fig 3A, 3C), occipital cortex (Fig S1A, S1C), thalamus (Fig S2A, S2C) and cerebellum (Fig S3A, S3C) from MV cases accumulated significantly more nonglycosylated forms than MM and VV cases.
###end p 39
###begin title 40
VV genotype
###end title 40
###begin p 41
###xml 23 33 23 33 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002786-g003">Fig 3B, 3C</xref>
###xml 46 58 46 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002786.s002">Fig S2B, S2C</xref>
###xml 76 83 76 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002786.s003">Fig S3C</xref>
###xml 93 101 <span type="species:ncbi:9606">patients</span>
###xml 172 180 <span type="species:ncbi:9606">patients</span>
###xml 188 196 <span type="species:ncbi:9606">patients</span>
In the frontal cortex (Fig 3B, 3C), thalamus (Fig S2B, S2C) and cerebellum (Fig S3C) from VV patients, diglycosylated forms were significantly more abundant compared to MV patients and MM patients.
###end p 41
###begin p 42
Therefore, a tendency was observed for each genotype to favour the accumulation of one glycoform in the frontal cortex, the occipital cortex, the thalamus and, to a lesser extent, in the cerebellum. Valine homozygosity favoured the diglycosylated form, methionine homozygosity favoured the monoglycosylated form, and heterozygosity favoured the nonglycosylated form.
###end p 42
###begin title 43
###xml 20 23 20 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
Influence of the PrPres type on glycoform diversity
###end title 43
###begin p 44
###xml 29 32 29 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 60 63 60 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 348 353 348 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002786-g004">Fig 4</xref>
We found that the type of PrPres affected the pattern of PrPres glycosylation in the thalamus, while little or no effect was detected in the other studied brain regions. Two distinct populations corresponding to MV1 and MV2 subgroups were evidenced. Subgroup MV2 had more diglycosylated forms and subgroup MV1 presented more nonglycosylated forms (Fig 4).
###end p 44
###begin title 45
###xml 20 23 20 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 35 38 35 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
Influence of the PrPres type on PrPres glycoforms in the thalamus.
###end title 45
###begin p 46
###xml 237 240 237 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 42 49 <span type="species:ncbi:9606">patient</span>
###xml 274 282 <span type="species:ncbi:9606">patients</span>
Each dot represents one brain area from a patient and is defined on the ternary plot by three coordinates corresponding to the relative intensity of di-, mono- and nonglycosylated bands. To rule out any codon effect, the influence of PrPres type was assessed in MV1 and MV2 patients. These two populations are almost separated on the ternary plot. A higher content of diglycosylated forms is observed in the heterozygote MV2 subgroup compared to the MV1 subgroup.
###end p 46
###begin p 47
###xml 35 38 35 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 109 112 109 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 207 221 207 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002786-g005">Fig 5A, 5C, 5E</xref>
###xml 339 353 339 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002786-g005">Fig 5B, 5D, 5F</xref>
In addition, the homogeneity of PrPres glycoform pattern between regions dramatically varies depending on PrPres types. Indeed, regression analysis demonstrated r values equal to or above 0,80 in MV1 group (Fig 5A, 5C, 5E) when correlating diglycosylated form ratio between regions, while r values from MV2 group ranged from 0,43 to 0,52 (Fig 5B, 5D, 5F). These lower correlations indicate a greater heterogeneity between glycoform ratio from different brain regions.
###end p 47
###begin title 48
###xml 20 23 20 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 35 38 35 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
Influence of the PrPres type on PrPres glycoforms.
###end title 48
###begin p 49
###xml 67 70 67 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 235 238 235 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 213 220 <span type="species:ncbi:9606">patient</span>
A strong correlation is observed between diglycoforms of type 1 PrPres from different brain regions (r values equal to or above 0.80) (A, C, E). On the contrary, the glycoform ratio varies to a larger extent when patient had type 2 PrPres (r values equal to or below 0.52) (B, D, F).
###end p 49
###begin title 50
Discussion
###end title 50
###begin p 51
###xml 56 59 56 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 265 268 265 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 342 346 342 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRNP</italic>
###xml 398 401 398 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 464 467 464 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
This study provides new insight into the analysis of PrPres heterogeneity within sCJD cases, based upon the biochemical analysis of at least 3 different brain regions from 123 sCJD cases. This large series of sCJD tissues allowed us to identify the diversity of PrPres glycoforms within sporadic CJD forms and to establish a correlation with PRNP genotype, brain region and Western blot type of PrPres. Our results demonstrate that the regional distribution of PrPres glycoforms within one individual is heterogeneous in the sporadic form of CJD and suggest the involvement of precise regulating mechanisms.
###end p 51
###begin p 52
###xml 105 106 105 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
###xml 166 170 166 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Beringue1">[14]</xref>
###xml 172 176 172 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-DeArmond2">[15]</xref>
###xml 178 182 178 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Kuczius1">[16]</xref>
###xml 230 233 230 233 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 417 418 417 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
###xml 456 459 456 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 547 548 547 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
###xml 644 647 644 647 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 647 651 647 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Vorberg1">[17]</xref>
###xml 721 725 721 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRNP</italic>
###xml 763 766 763 766 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 869 870 869 870 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
###xml 890 894 890 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRNP</italic>
###xml 76 81 <span type="species:ncbi:9606">human</span>
###xml 95 100 <span type="species:ncbi:10090">mouse</span>
###xml 196 201 <span type="species:ncbi:9606">human</span>
###xml 976 981 <span type="species:ncbi:9606">human</span>
Different factors may contribute to this regulation. In the normal brain of human, hamster and mouse, PrPc glycosylation pattern is submitted to a regional diversity [14], [15], [16]. In infected human brains, the diversity of PrPres glycoprofiles may result from such a regional variation of the substrate for prion replication. According to the prion hypothesis, this mechanism suggests that the glycoprofile of PrPc influences the glycoform ratio of PrPres in the conversion process. In acellular models of PrP conversion indeed, the use of PrPc with modified glycoforms ratio partially modifies the glycosylation pattern of newly formed PrPres[17]. In the present study, we observed that the genotype at codon 129 of PRNP influenced the glycoform ratio of PrPres in a region dependent manner. This raises the possibility that the regional glycosylation state of PrPc may be affected by PRNP polymorphisms. It may be of interest to document such a regulation in the normal human brain.
###end p 52
###begin p 53
###xml 82 86 82 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRNP</italic>
###xml 104 107 104 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 262 266 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-GrasbonFrodl1">[18]</xref>
###xml 268 272 268 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Hill1">[19]</xref>
###xml 346 347 346 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
###xml 481 484 481 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 507 508 507 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
###xml 545 549 545 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Chasseigneaux1">[20]</xref>
###xml 644 645 644 645 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
###xml 703 706 703 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 355 360 <span type="species:ncbi:9606">human</span>
###xml 426 434 <span type="species:ncbi:9606">patients</span>
Several studies have pointed out a relation between PrP amino acid sequence (i.e. PRNP genotype) and PrPres glycosylation in inherited diseases associated to mutation located close to (D178N, V180I, T183A, E200K) or remote (P102L) from the N-glycosylation sites [18], [19]. Whether the presence of a mutation may modify the glycoform ratio of PrPc in the human brain is poorly documented. However we previously showed that in patients with the V180I mutation, no diglycosylated PrPres is produced, while PrPc glycosylation is normally processed [20]. This clearly indicates that additional factors, different from the glycosylation state of PrPc, may influence the glycoform ratio of the accumulated PrPres in the pathological condition.
###end p 53
###begin p 54
###xml 20 23 20 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 157 160 157 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 221 224 221 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 399 402 399 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 470 473 470 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 588 589 588 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
###xml 841 844 841 844 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 850 854 850 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Collinge2">[21]</xref>
###xml 1012 1015 1012 1015 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 336 344 <span type="species:ncbi:9606">patients</span>
Type 1 or type 2 PrPres are thought to correspond to distinct accessibilities of proteinase K to cleavage sites resulting from different conformations of PrPres. A diversity of glycotypes has been described for type 2 PrPres, linked to the various forms of the diseases (sporadic, variant CJD, familial fatal insomnia). In sporadic CJD patients with the same genotype at codon 129, we found that PrPres type markedly influences the glycoform ratio of the accumulated PrPres in definite brain regions. This suggests that some conformers are more prone to convert distinct glycoforms of PrPc in sporadic diseases and that this phenomenon is regionally regulated. In addition, to explain the strain mutation phenomenon, it has been recently proposed that a single strain may consist of an ensemble of molecular species containing a dominant PrPres type [21]. Such conformers may differ by the glycoform species they favor during replication. It can be speculated that regional factors influence the selection of PrPres subpopulations leading to the variation of the glycoform ratio that we finally detected.
###end p 54
###begin p 55
###xml 29 32 29 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 315 318 315 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 368 372 368 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-DeArmond1">[12]</xref>
###xml 374 378 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Tuzi1">[13]</xref>
###xml 380 384 380 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Somerville1">[22]</xref>
###xml 484 487 484 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 957 960 957 960 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 1249 1250 1249 1250 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
###xml 1259 1262 1259 1262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 747 755 <span type="species:ncbi:9606">patients</span>
###xml 979 985 <span type="species:ncbi:9913">bovine</span>
###xml 1518 1524 <span type="species:ncbi:9913">bovine</span>
###xml 1539 1547 <span type="species:ncbi:9606">patients</span>
The regional variation of PrPres glycoform ratio demonstrated in this study may be of interest in the understanding of "lesion profile" and brain targeting by different prion strains. The mechanisms that favor the accumulation of a given strain in a given brain region are not known, but the regulation of PrPc/ PrPres glycosylation is likely involved in this process [12], [13], [22]. As a matter of fact, we found in sCJD cases that the thalamus favored the production of type 2 PrPres presenting a high content in diglycosylated forms. It is noteworthy that besides sCJD, vCJD and FFI are associated with a high content of diglycosylated forms and are characterized by a "targeting" of the thalamus. In all studied brain areas from French vCJD patients, as already reported in the U.K. cases, we observed that the glycoform ratio was remarkably constant. In this infectious form of prion disorders, the pathogenic events are initiated by an exogenous PrPres from contaminated bovine tissues with its own defined characteristics, such as a high glysosylated content that is maintained through interspecies transmission. By contrast, the causative event in sCJD is thought to be a rare, spontaneous and endogenous conversion of the host-encoded PrPc into PrPres. The diversity of glycoform ratios that we observed in sCJD may reflect the regulation of an endogenous phenomenon by various host factors (genotype, brain region) that may be overwhelmed in the case of an infection by a virulent prion strain such as the bovine agent in vCJD patients.
###end p 55
###begin p 56
###xml 22 25 22 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 125 128 125 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 154 157 154 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 350 353 350 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 416 419 416 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 633 637 633 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Asante1">[23]</xref>
###xml 1228 1232 1228 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-ChadeauHyam1">[24]</xref>
###xml 1432 1435 1432 1435 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 1543 1546 1543 1546 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 1640 1645 1640 1645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002786-g006">Fig 6</xref>
###xml 259 267 <span type="species:ncbi:9606">patients</span>
###xml 299 307 <span type="species:ncbi:9606">patients</span>
###xml 466 481 <span type="species:ncbi:10090">transgenic mice</span>
###xml 493 498 <span type="species:ncbi:9606">human</span>
###xml 595 601 <span type="species:ncbi:9606">humans</span>
###xml 766 774 <span type="species:ncbi:9606">patients</span>
###xml 965 973 <span type="species:ncbi:9606">patients</span>
###xml 1363 1371 <span type="species:ncbi:9606">patients</span>
###xml 1593 1601 <span type="species:ncbi:9606">patients</span>
###xml 1676 1684 <span type="species:ncbi:9606">patients</span>
Our observation of PrPres glycoprofile diversity in sCJD raises the question of the strain diagnosis based on biochemical PrPres analysis. The type 2B PrPres profile is widely used as a diagnosis marker of definite vCJD that until now has been observed in MM patients only. However, in some VV2 CJD patients, the high proportion of diglycosylated PrPres we observed in the thalamus was undistinguishable from the PrPres profile detected in vCJD cases. Studies using transgenic mice expressing human PrP suggest that clinicopathological and biochemical presentations of BSE infection may vary in humans with the genotype at codon 129 [23]. One possible explanation of our findings in these particular VV2 cases could be BSE infection (i.e. vCJD) in valine homozygote patients. However, the mean age at death (>65 years, except one case who was 27) and the neuropathological pattern (absence of florid plaques) do not support such hypothesis. While the first MM vCJD patients occurred simultaneously in UK and France, the peak of French vCJD epidemics occurred in 2002 more than 5 years later than in the UK. Comparison of the 1980-1995 pattern of BSE exposition in the UK and France indicated that it peaked also later in France [24]. This probably explains the different temporal pattern of vCJD incidence. We analyzed retrospectively whether some French VV2 CJD patients who died between 1993 and 1999 exhibited also a thalamic PrPres profile with high glycosylation site occupancy similar to what is observed in vCJD. The same profile of PrPres ressembling type 2B could also be detected in patients who died during the 1993-1999 period (Fig 6). This suggests that these VV patients had indeed a genuine sporadic disease rather than an atypical vCJD, which is very unlikely to have occurred in an unrelated genotype and before 1996 in France.
###end p 56
###begin title 57
###xml 11 14 11 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 97 105 <span type="species:ncbi:9606">patients</span>
###xml 115 123 <span type="species:ncbi:9606">patients</span>
Similar PrPres glycoform ratios with high glycosylation site occupancy in thalamus from VV2 sCJD patients and vCJD patients.
###end title 57
###begin p 58
###xml 42 49 <span type="species:ncbi:9606">patient</span>
###xml 207 215 <span type="species:ncbi:9606">patients</span>
###xml 246 254 <span type="species:ncbi:9606">patients</span>
###xml 269 277 <span type="species:ncbi:9606">patients</span>
###xml 383 391 <span type="species:ncbi:9606">patients</span>
###xml 426 434 <span type="species:ncbi:9606">patients</span>
Each dot represents one brain area from a patient and is defined on the ternary plot by three coordinates corresponding to the relative intensity of di-, mono- and nonglycosylated bands. We compared the VV2 patients from our sCJD series and vCJD patients with VV2 sCJD patients who died before or just after the first variant breakout in 1996. No difference was observed between VV2 patients from the 2000-2007 series and VV2 patients from the period 1993-1999.
###end p 58
###begin p 59
###xml 97 100 97 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 201 204 201 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 225 233 225 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002786-g007">figure 7</xref>
###xml 139 147 <span type="species:ncbi:9606">patients</span>
Finally, the present work evidences regulations that lead to highly significant variations of PrPres pattern between brain regions in sCJD patients, involving host genotype and Western blot type of PrPres as recapitulated in figure 7. These may contribute to the specific brain targeting of prion strains and have some diagnosis implications.
###end p 59
###begin title 60
###xml 45 48 45 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
Schematic representation of regulation of PrPres glycoforms by regional and molecular factors in sporadic Creutzfeldt-Jakob disease.
###end title 60
###begin p 61
###xml 38 41 38 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 129 132 129 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 201 204 201 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 167 175 <span type="species:ncbi:9606">patients</span>
Arrows indicate which glycoform of PrPres is favored by individual factors. As an example, the accumulation of diglycosylated PrPres is favored in the thalamus, in VV patients and in case of type 2 PrPres.
###end p 61
###begin title 62
Methods
###end title 62
###begin title 63
Case and tissue selection
###end title 63
###begin p 64
###xml 257 261 257 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Budka1">[25]</xref>
###xml 28 36 <span type="species:ncbi:9606">patients</span>
###xml 268 276 <span type="species:ncbi:9606">patients</span>
###xml 423 431 <span type="species:ncbi:9606">Patients</span>
###xml 527 535 <span type="species:ncbi:9606">patients</span>
###xml 811 819 <span type="species:ncbi:9606">patients</span>
This study was performed on patients referred to the French National Surveillance Network for CJD during the period january 2000 to march 2007 and for which clinical, genetic and neuropathological data were available to support a diagnosis of definite sCJD [25]. Only patients with at least three available regions out of the four studied (frontal cortex, occipital cortex, thalamus and cerebellar vermis) were considered. Patients with familial and iatrogenic CJD were excluded from the study. We included 123 sCJD cases (103 patients had 4 available regions), 55 male and 68 female subjects, and the mean age at death was 68 (range, 24-90 years). In addition, a group of 11 french vCJD cases was also studied, comprising of 4 male and 7 female subjects. The mean age at death was 36 (range, 20-58 years). The patients' relatives gave written informed consent for autopsy, and the study was designed in accordance with the relevant French legislation.
###end p 64
###begin title 65
PRNP analysis
###end title 65
###begin p 66
###xml 149 153 149 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRNP</italic>
###xml 238 242 238 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Peoch1">[26]</xref>
###xml 109 117 <span type="species:ncbi:9606">patients</span>
DNA was extracted from buffy coat fraction of peripheral blood after obtaining written informed consent from patients. Codon 129 polymorphism of the PRNP gene and the absence of mutation or insertion was determined as described elsewhere [26].
###end p 66
###begin title 67
###xml 27 30 27 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
Biochemical analysis of PrPres
###end title 67
###begin p 68
###xml 457 460 441 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 506 507 490 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 664 668 648 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Lasmezas1">[27]</xref>
###xml 1116 1120 1100 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Kascsak1">[28]</xref>
###xml 1304 1307 1288 1291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 1444 1447 1428 1431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Head1">[8]</xref>
###xml 1467 1470 1451 1454 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 1575 1578 1559 1562 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 1706 1709 1690 1693 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 1724 1727 1708 1711 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 1852 1855 1836 1839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Parchi2">[6]</xref>
###xml 1909 1912 1893 1896 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 1982 1985 1966 1969 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 2198 2202 2182 2186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRNP</italic>
###xml 2233 2236 2217 2220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 2242 2245 2226 2229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Parchi3">[7]</xref>
###xml 2288 2291 2272 2275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 2401 2404 2385 2388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Head1">[8]</xref>
###xml 2406 2409 2390 2393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Puoti1">[9]</xref>
###xml 2411 2415 2395 2399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Polymenidou1">[29]</xref>
###xml 930 935 <span type="species:ncbi:9606">human</span>
###xml 1122 1126 <span type="species:ncbi:9925">Goat</span>
###xml 1132 1137 <span type="species:ncbi:10090">mouse</span>
###xml 1157 1168 <span type="species:ncbi:3704">horseradish</span>
Frozen tissue was stored at -80degreesC. Brains were homogenized at 20% (w/v) using a Ribolyser (Bio-Rad) in 5% sterile glucose. One volume of a 20% NaCl solution and one volume of a detergent solution (20% sarkosyl, 2% SB3-14 and Tris 20 mM pH 7.4) were added to one volume of 20% brain homogenate. This mixture had a final pH of 7.6 and was digested with proteinase K at 10 microg/ml (diluted in Tris-HCl 50 mM pH 8, CaCl2 1 mM) for 1 h at 37degreesC. PrPres was then purified by centrifugation at 27500 g for 2 h at room temperature on 20% sucrose cushion, according to the scrapie-associated fibril (SAF) protocol reported previously with slight modifications [27]. Samples were subjected to a 12% Tris-glycine sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Proteins were electroblotted onto nitrocellulose membrane. PrP staining was performed using anti-PrP monoclonal antibody 3F4, epitope 109-112 of human PrP sequence (Signet, MA, USA) at a dilution of 1 to 50000, and chemiluminescence (ECL; RPN-2209; Amersham Biosciences, Freiburg, Germany) for the detection of peroxidase activity [28]. Goat anti-mouse secondary antibody horseradish peroxidase conjugated used was from Pierce Biotechnology (31430, Rockford, IL) and used at a dilution of 1 to 5000. Quantitation of PrPres glycoforms was performed using a GS-800 calibrated densitometer and dedicated Quantity One software (Bio-Rad Laboratories) as described [8]. Values for all PrPres bands were measured on blots with a non-saturated signal and calculated as a percentage of the total PrPres. When necessary, additional blots were performed with serially diluted samples to obtain a signal in a linear range. Type 1 PrPres and type 2 PrPres were characterized by a nonglycosylated band migrating at 21 kDa and at 19 kDa, respectively, as described by Parchi et al. [6]. Typical standards of type 1, type 2A and type 2B PrPres were systematically included to facilitate Western blot typing of PrPres. Molecular weights were determined using a protein standard (Novex Sharp Standard, Invitrogen). Cases of sCJD were classified according to Parchi et al. that identified six molecular subtypes on the basis of the PRNP codon 129 polymorphism and PrPres type [7]. Cases of sCJD for which both types of PrPres were detected using 3F4 antibody in a same brain region or in different regions were excluded from the study [8], [9], [29].
###end p 68
###begin title 69
Statistical analysis
###end title 69
###begin p 70
###xml 128 129 128 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 293 297 293 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002786-Glatzel1">[30]</xref>
Linear regression, correlation and non parametric tests were carried out using StatView v4.0 (Abacus Concepts, Berkeley, CA). A p value of less than 0.05 was considered to be statistically significant. Glycoform ratios were visualized on ternary plot as originally described by Glatzel et al. [30]. Automated graphical representations were generated using JMP software v6.0.0 (SAS).
###end p 70
###begin title 71
Supporting Information
###end title 71
###begin p 72
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRNP</italic>
###xml 43 46 43 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 98 106 <span type="species:ncbi:9606">patients</span>
###xml 229 237 <span type="species:ncbi:9606">patients</span>
###xml 316 324 <span type="species:ncbi:9606">patients</span>
Influence of PRNP codon 129 genotype on PrPres glycoform ratios in the occipital cortex from sCJD patients. This brain region was less affected by genotype than the frontal cortex and the thalamus. However, methionine homozygote patients showed more monoglycosylated forms (A, B) and methionine/ valine heterozygote patients were associated with a predominance of nonglycosylated forms (A, C).
###end p 72
###begin p 73
(3.75 MB TIF)
###end p 73
###begin p 74
Click here for additional data file.
###end p 74
###begin p 75
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRNP</italic>
###xml 43 46 43 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 90 98 <span type="species:ncbi:9606">patients</span>
###xml 222 230 <span type="species:ncbi:9606">patients</span>
###xml 300 308 <span type="species:ncbi:9606">patients</span>
###xml 372 380 <span type="species:ncbi:9606">patients</span>
Influence of PRNP codon 129 genotype on PrPres glycoform ratios in the thalamus from sCJD patients. Marked differences were observed in this brain region. More monoglycosylated forms were detected in methionine homozygote patients compared to other genotypes (A, B,). Methionine/ valine heterozygote patients presented more nonglycosylated forms (A, C). Valine homozygote patients had more diglycosylated forms (B, C).
###end p 75
###begin p 76
(3.81 MB TIF)
###end p 76
###begin p 77
Click here for additional data file.
###end p 77
###begin p 78
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRNP</italic>
###xml 43 46 43 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">res</sup>
###xml 92 100 <span type="species:ncbi:9606">patients</span>
###xml 250 258 <span type="species:ncbi:9606">patients</span>
###xml 352 360 <span type="species:ncbi:9606">patients</span>
###xml 454 462 <span type="species:ncbi:9606">patients</span>
Influence of PRNP codon 129 genotype on PrPres glycoform ratios in the cerebellum from sCJD patients. Like the occipital cortex, this brain region was less affected by genotype than the frontal cortex and the thalamus. However, methionine homozygote patients remained associated with more monoglycosylated forms (A, B), methionine/ valine heterozygote patients were associated with a predominance of nonglycosylated forms (A, C), while valine homozygote patients clearly presented more diglycosylated forms (B, C).
###end p 78
###begin p 79
(3.81 MB TIF)
###end p 79
###begin p 80
Click here for additional data file.
###end p 80
###begin p 81
We thank Agueda Matos for her technical expertise.
###end p 81
###begin title 82
References
###end title 82
###begin article-title 83
Identification of a protein that purifies with the scrapie prion.
###end article-title 83
###begin article-title 84
Prions.
###end article-title 84
###begin article-title 85
###xml 71 76 <span type="species:ncbi:9606">human</span>
Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies.
###end article-title 85
###begin article-title 86
Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism.
###end article-title 86
###begin article-title 87
Genetic influence on the structural variations of the abnormal prion protein.
###end article-title 87
###begin article-title 88
Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease.
###end article-title 88
###begin article-title 89
Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects.
###end article-title 89
###begin article-title 90
Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002.
###end article-title 90
###begin article-title 91
Sporadic Creutzfeldt-Jakob disease: co-occurrence of different types of PrP(Sc) in the same brain.
###end article-title 91
###begin article-title 92
Diversity of oligosaccharide structures linked to asparagines of the scrapie prion protein.
###end article-title 92
###begin article-title 93
Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD.
###end article-title 93
###begin article-title 94
Selective neuronal targeting in prion disease.
###end article-title 94
###begin article-title 95
Host PrP glycosylation: a major factor determining the outcome of prion infection.
###end article-title 95
###begin article-title 96
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
Regional heterogeneity of cellular prion protein isoforms in the mouse brain.
###end article-title 96
###begin article-title 97
PrPc glycoform heterogeneity as a function of brain region: implications for selective targeting of neurons by prion strains.
###end article-title 97
###begin article-title 98
###xml 71 76 <span type="species:ncbi:9606">human</span>
Regional and phenotype heterogeneity of cellular prion proteins in the human brain.
###end article-title 98
###begin article-title 99
Molecular basis of scrapie strain glycoform variation.
###end article-title 99
###begin article-title 100
###xml 60 65 <span type="species:ncbi:9606">human</span>
Loss of glycosylation associated with the T183A mutation in human prion disease.
###end article-title 100
###begin article-title 101
Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations.
###end article-title 101
###begin article-title 102
V180I mutation of the prion protein gene associated with atypical PrPSc glycosylation.
###end article-title 102
###begin article-title 103
A general model of prion strains and their pathogenicity.
###end article-title 103
###begin article-title 104
Host and transmissible spongiform encephalopathy agent strain control glycosylation of PrP.
###end article-title 104
###begin article-title 105
###xml 104 109 <span type="species:ncbi:9606">human</span>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
Dissociation of pathological and molecular phenotype of variant Creutzfeldt-Jakob disease in transgenic human prion protein 129 heterozygous mice.
###end article-title 105
###begin article-title 106
Estimation of the exposure of the French population to the BSE agent: comparison of the 1980-95 consumption of beef products containing mechanically recovered meat in France and the UK, by birth cohort and gender.
###end article-title 106
###begin article-title 107
###xml 84 89 <span type="species:ncbi:9606">human</span>
Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases).
###end article-title 107
###begin article-title 108
Identification of three novel mutations (E196K, V203I, E211Q) in the prion protein gene (PRNP) in inherited prion diseases with Creutzfeldt-Jakob disease phenotype.
###end article-title 108
###begin article-title 109
###xml 33 37 <span type="species:ncbi:10090">mice</span>
Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein.
###end article-title 109
###begin article-title 110
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins.
###end article-title 110
###begin article-title 111
Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease.
###end article-title 111
###begin article-title 112
Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease.
###end article-title 112
###begin p 113
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 113
###begin p 114
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants from Region Ile-de-France and INVS. B.A.F. acknowledges funding from the Assistance Publique-HA'pitaux de Paris (Delegation a la Recherche Clinique et au Developpement).
###end p 114

